Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha (Nr1d1) Rescues Nr2e3 Associated Retinal Disease
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate processes such as metabolism, circadian function, and development. They function in these processes to maintain homeostasis through modulation of transcriptional gene networks. In this study we evaluate the effectiveness of a nuclear hormone receptor gene to modulate retinal degeneration and restore the integrity of the retina. Currently, there are no effective treatment options for retinal degenerative diseases leading to progressive and irreversible blindness. In this study we demonstrate that the nuclear hormone receptor gene Nr1d1 (Rev-Erbα) rescues Nr2e3-associated retinal degeneration in the rd7 mouse, which lacks a functional Nr2e3 gene. Mutations in human NR2E3 are associated with several retinal degenerations including enhanced S cone syndrome and retinitis pigmentosa. The rd7 mouse, lacking Nr2e3, exhibits an increase in S cones and slow, progressive retinal degeneration. A traditional genetic mapping approach previously identified candidate modifier loci. Here, we demonstrate that in vivo delivery of the candidate modifier gene, Nr1d1 rescues Nr2e3 associated retinal degeneration. We observed clinical, histological, functional, and molecular restoration of the rd7 retina. Furthermore, we demonstrate that the mechanism of rescue at the molecular and functional level is through the re-regulation of key genes within the Nr2e3-directed transcriptional network. Together, these findings reveal the potency of nuclear receptors as modulators of disease and specifically of NR1D1 as a novel therapeutic for retinal degenerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that modifier genes, such as nuclear hormone receptors, have the potential to “reset” various networks related to retinal disease phenotypes, such as photoreceptor development, phototransduction, metabolism, cone cell development, inflammation, and cell survival, thus restoring the homeostasis in the retina to a healthy state.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Modifier gene therapy has the potential to alter the retinal disease state even in the absence of a genetic diagnosis or in the absence of a gene therapy specific to the mutated gene in one of these patients.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Electroporation and RNA interference in the rodent retina in vivo and in vitro
Matsuda, T., & Cepko, C. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235688100 · Cited by 1,029
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Nuclear Receptor Rev-erbα Is a Critical Lithium-Sensitive Component of the Circadian Clock
Yin, L., Wang, J., Klein, P. S., & Lazar, M. A. (2006) · Science · doi:10.1126/science.1121613 · Cited by 556
Simonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.277 · Cited by 553
Haider, N. B., Jacobson, S. G., Cideciyan, A. V., Swiderski, R., Streb, L. M., Searby, C., Beck, G., Hockey, R., Hanna, D. B., Gorman, S., et al. (2000) · Nature Genetics · doi:10.1038/72777 · Cited by 507
Self-citationStorch, K.-F., Paz, C., Signorovitch, J., Raviola, E., Pawlyk, B., Li, T., & Weitz, C. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.045 · Cited by 460 · cited 2×
“In the retina, both Nr2e3 and Nr1d1 mRNA levels oscillate over a 24-hour period [45].”
BackgroundCideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Pang, J.-J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.086 · Cited by 312
Modifier genes in Mendelian disorders: the example of cystic fibrosis
Cutting, G. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05879.x · Cited by 271
Peng, G.-H., Ahmad, O., Ahmad, F., Liu, J., & Chen, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi070 · Cited by 270
Cited by
From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health
Riordan, J. D., & Nadeau, J. H. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.004 · Cited by 169
“Fine-mapping of a candidate protective locus led to the identification of Nr1d1 (nuclear receptor subfamily 1, group D, member 1) as a modifier gene whose increased expression compensates for loss of Nr2e3 to eliminate the disease phenotype.(93) Nr1d1 encodes the nuclear hormone receptor Rev-erba, a target for which m…”
BackgroundGene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
Collin, G. B., Gogna, N., Chang, B., Damkham, N., Pinkney, J., Hyde, L. F., Stone, L. V., Naggert, J. Κ., Nishina, P. M., & Krebs, M. P. (2020) · Cells · doi:10.3390/cells9040931 · Cited by 105
“Causality was confirmed by phenotypic rescue of the rd7-associated phenotypes by in vivo electroporation of a wild-type Nr1d1 expression construct [464].”
BackgroundOcular Clocks: Adapting Mechanisms for Eye Functions and Health
Felder‐Schmittbuhl, M., Buhr, E. D., Dkhissi‐Benyahya, O., Hicks, D., Peirson, S. N., Ribelayga, C., Sandu, C., Spessert, R., & Tosini, G. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24957 · Cited by 103
Li, S., Datta, S., Brabbit, E., Love, Z., Woytowicz, V., Flattery, K., Capri, J., Yao, K., Wu, S., Imboden, M., et al. (2021) · Gene Therapy · doi:10.1038/s41434-020-0134-z · Cited by 68
“Genetic modi fi ers play a key role in modulating disease onset, progression, and clinical outcome by either enhancing or suppressing disease [24, 40].”
BackgroundSelf-citationde Carvalho, E. R., Robson, A. G., Arno, G., Boon, C. J. F., Webster, A. R., & Michaelides, M. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.07.008 · Cited by 68
Hafler, B. P. (2016) · Retina · doi:10.1097/iae.0000000000001341 · Cited by 67
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“Genetic overexpression of REV-ERBα as a modifier gene rescues Nr2e3 -associated retinal degeneration in rd7 mice (Cruz et al., 2014).”
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases
Ana Maria, A., Oscar Andréas, M.-R., & Haider, N. B. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25480 · Cited by 59
Self-citationRev‐Erbα modulates retinal visual processing and behavioral responses to light
Hakkari, O. A.-H., Acar, N., Savier, E. L., Spinnhirny, P., Bennis, M., Felder‐Schmittbuhl, M., Mendoza, J., & Hicks, D. (2016) · The FASEB Journal · doi:10.1096/fj.201600414r · Cited by 43
“The large differences between the 2 studies possibly come from the approach used here (total gene deletion) compared with partial small interfering RNA knockdown, or because of influences of endogenous transcription factors as modifiers (19).”
BackgroundGenetic disorders of nuclear receptors
Achermann, J. C., Schwabe, J. W. R., Fairall, L., & Chatterjee, K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88892 · Cited by 42
“Another NR, Rev-erb-α /NR1D1, has been used to potentially “rescue” disease progression in the rd7 mouse (64).”
Evolution of the visual sensory system in cichlid fishes from crater lake Barombi Mbo in Cameroon
Musilová, Z., Indermaur, A., Nyom, A. R. B., Omelchenko, D., Kłodawska, M., Albergati, L., Remišová, K., & Salzburger, W. (2019) · Molecular Ecology · doi:10.1111/mec.15217 · Cited by 38
“…retina degeneration such as retinis pigmentosa and S‐cone syndrome (dominance of S‐cones over other cones and rods) in human Mollema et al. (2011), Cruz et al. (2014) Circadian clock Transcription factor Huang, Zhang, Ye, and Wang (2016) 6 LG3b per1 3.49 4.98 4.16 2.82 2.00 Circadian clock…”
BackgroundInfluentialSchil, K. V., Karlstetter, M., Aslanidis, A., Dannhausen, K., Azam, M., Qamar, R., Leroy, B. P., Depasse, F., Langmann, T., & Baere, E. B. W. D. (2016) · Scientific Reports · doi:10.1038/srep21307 · Cited by 42
Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina
Kunst, S., Wolloscheck, T., Kelleher, D. K., Wolfrum, U., Sargsyan, S. A., Iuvone, P. M., Baba, K., Tosini, G., & Spessert, R. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17503 · Cited by 36
Cone Vision Changes in the Enhanced S-Cone Syndrome Caused by NR2E3 Gene Mutations
Garafalo, A. V., Calzetti, G., Cideciyan, A. V., Román, A. J., Saxena, S., Sumaroka, A., Choi, W., Wright, A. F., & Jacobson, S. G. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24518 · Cited by 32
Milićević, N., Mazzaro, N., de Bruin, I., Wils, E., ten Brink, J. B., ten Asbroek, A. L. M. A., Mendoza, J., Bergen, A. A. B., & Felder‐Schmittbuhl, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-48203-3 · Cited by 29
Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV
Grishchuk, Y., Stember, K. G., Matsunaga, A., Olivares, A. M., Cruz, N. M., King, V. E., Humphrey, D. M., Wang, S. L., Muzikansky, A., Betensky, R. A., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.017 · Cited by 26
Self-citationLlavona, P., Pinelli, M., Mutarelli, M., Marwah, V. S., Schimpf‐Linzenbold, S., Thaler, S., Yoeruek, E., Vetter, J. M., Kohl, S., & Wissinger, B. (2017) · Genes · doi:10.3390/genes8100283 · Cited by 26
Akula, M., McNamee, S. M., Love, Z., Nasraty, N., Chan, N. P. M., Whalen, M., Avola, M. O., Olivares, A. M., Leehy, B. D., Jelcick, A. S., et al. (2024) · Gene Therapy · doi:10.1038/s41434-024-00455-z · Cited by 24
Self-citationCircadian clocks, retinogenesis and ocular health in vertebrates: new molecular insights
Béry, A., Bagchi, U., Bergen, A. A. B., & Felder‐Schmittbuhl, M. (2022) · Developmental Biology · doi:10.1016/j.ydbio.2022.02.001 · Cited by 25
Genetic modifiers as relevant biological variables of eye disorders
Meyer, K. J., & Anderson, M. G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx180 · Cited by 23
Nuclear Receptor Subfamily 2 Group E Member 3 (NR2E3): Role in Retinal Development and Disease
Toms, M., Ward, N., & Moosajee, M. (2023) · Genes · doi:10.3390/genes14071325 · Cited by 21
Román, A. J., Powers, C. A., Semenov, E. P., Sheplock, R., Aksianiuk, V., Russell, R. C., Sumaroka, A., Garafalo, A. V., Cideciyan, A. V., & Jacobson, S. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102497 · Cited by 19
“The disease expression of ESCS patients with NR2E3 gene mutations was recently reassessed, considering promising proof-of-concept murine research that could lead to clinical trials of treatment [13,14,17].”
BackgroundGene-agnostic approaches to treating inherited retinal degenerations
Chew, L. A., & Iannaccone, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1177838 · Cited by 17
“, 2019; Batabyal and Kim, 2021), augmenting expression of the nuclear hormone receptor NR1D1 led to histological and molecular restoration of the rd7 retina (Cruz et al., 2014).”
BackgroundRethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases
Choudhary, M., & Malek, G. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116659856 · Cited by 17
“Finally, Nr1d1 gene delivery was also able to reregulate the key genes that are vital for photoreceptor homeostasis, which were misregulated by the absence of Nr2e3 in Nr2e3 mice.(48) This study established Nr1d1 as a potential therapeutic target that may be used as a tool for gene Table 2.”
MethodPotential therapeutic targets for age-related macular degeneration: The nuclear option
Choudhary, M., & Malek, G. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101130 · Cited by 15
“Importantly, PNR administered therapy has been shown to reduce retinal degeneration in preclinical models of retinitis pigmentosa (Cruz et al., 2014; Haider et al., 2008; Li et al., 2021).”
BackgroundInterspecies Correlations between Human and Mouse NR2E3-Associated Recessive Disease
Iannaccone, A., Brabbit, E., Lopez-Miro, C., Love, Z., Griffiths, V., Kedrov, M., & Haider, N. B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030475 · Cited by 15
“Fundus and OCT were performed as previously described [43,49,50].”
MethodSelf-citationOlivares, A. M., Han, Y., Soto, D. R., Flattery, K., Marini, J., Mollema, N., Haider, A., Escher, P., DeAngelis, M. M., & Haider, N. B. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.05.021 · Cited by 13
“There are several examples of genetic modifier genes in the retina and other tissues that influence time of disease onset and progression (Houlston and Tomlinson, 1998; Cruz et al., 2014).”
Self-citationNovel Pathogenic Sequence Variants in NR2E3 and Clinical Findings in Three Patients
Al‐Khuzaei, S., Broadgate, S., Halford, S., Jolly, J. K., Shanks, M. E., Clouston, P., & Downes, S. M. (2020) · Genes · doi:10.3390/genes11111288 · Cited by 12
“There are many factors can influence the range of phenotypes seen in a disease including; epigenetic factors, environment, allelic heterogeneity and genetic modifiers [45,49,50].”
BackgroundIdentification of potential biomarkers of myopia based on machine learning algorithms
Zhang, S., Wang, T., Wang, H., Gao, B., & Sun, C. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03119-5 · Cited by 10
“NR1D1 is involved in metabolism, autophagy, cell proliferation, inflammation and other processes and regulates a variety of diseases [20–22].”
BackgroundMcNamee, S. M., Chan, N. P., Akula, M., Avola, M. O., Whalen, M., Nystuen, K., Singh, P., Upadhyay, A. K., DeAngelis, M. M., & Haider, N. B. (2024) · Gene Therapy · doi:10.1038/s41434-024-00440-6 · Cited by 10
Self-citationRecognizable Patterns of Submacular Fibrosis in Enhanced S-Cone Syndrome
Alsalamah, A. K., Khan, A. O., Bakar, A. A., Schatz, P., & Nowilaty, S. R. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2021.03.014 · Cited by 10
Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity
Lopes‐Marques, M., Pacheco, A. R., Peixoto, M. J., Cardoso, A. R., Serrano, C., Amorim, A., Prata, M. J., Cooper, D. N., & Azevedo, L. (2021) · Human Mutation · doi:10.1002/humu.24221 · Cited by 10
“…modifiers within the regulatory regions of key genes involved in cystic fibrosis, sickle cell disease, retinitis pigmentosa, and OTC deficiency (Cruz et al., 2014; Darrah et al., 2010; Hillian et al., 2008; Jang et al., 2018; Li et al., 2020; Luksan et al., 2010; Steinberg & Sebastiani, 2012)…”
BackgroundPeavey, J. J., Parmar, V. M., & Malek, G. (2022) · Cells · doi:10.3390/cells11152386 · Cited by 8
“Other downregulated genes included PPARα, shown to play a role in retinopathy of prematurity [51], REV-ERBα and REV-ERBβ, potential regulators of circadian rhythm and receptors which have been linked to retinitis pigmentosa (RP) through regulation of PNR [52].”
BackgroundCehajic‐Kapetanovic, J., Cottriall, C. L., Jolly, J. K., Shanks, M. E., Clouston, P., Issa, P. C., & MacLaren, R. E. (2018) · Ophthalmic Genetics · doi:10.1080/13816810.2018.1547912 · Cited by 6
“Nonetheless, NR2E3 continues to be expressed in adult life, and boosting its function or that of its modifier genes (26) with gene replacement therapy might help to maintain normal photoreceptor function and prolong survival.”
BackgroundArany, E. S., Olimpio, C., Paramonov, I., & Horváth, R. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01860-7 · Cited by 3
Babiloni-Chust, I., Donato, L., Sartori, S., Carl, M., Zerti, D., Rinaldi, C., Flati, V., Feligioni, M., D’Angelo, R., Maccarone, R., et al. (2026) · Antioxidants · doi:10.3390/antiox15030348 · Cited by 3
“As key integrators of rhythmic timing and homeostasis, Rev-erbs are essential for retinal differentiation and survival [69–71].”
Modeling Retinitis Pigmentosa with Patient-Derived iPSCs
Leong, Y. C., & Sowden, J. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-27681-1_81 · Cited by 2
Bhat, M. A., & Goyal, S. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10927-3 · Cited by 1
“It is still unclear whether these cells can form durable, functional synapses with the host visual circuitry [ 70 , 71].”
Upadhyay, A. K., Drag, S., Singh, P., Rajanala, K., & Arumugham, R. G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1679619 · Cited by 1
Zhang, S., Wang, T., Wang, H., Gao, B., & Sun, C. (2023) · Figshare · doi:10.6084/m9.figshare.24186208
Escher, P. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197659403.003.0035
Self-citationSharov, A. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.09.687492
Mutational change of X-linked disease genes in both the pathological and the evolutionary context
Serrano, C. T. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/7ctv-jv92
Role of the Glycogen Synthase Kinase 3 for the Retinal Development and Homeostasis
Braginskaja, E. (2018) · theses.fr (ABES) · doi:10.70675/72532a81z164ez4786z8c84zaf55afbdfa1d
“Interestingly, Nr1d1 can rescue Nr2e3 loss in the rd7 mouse mutant described above with clinical, histological, functional and molecular restoration, demonstrating the functional redundancy of the two factors (Cruz et al., 2014).”
Circadian regulation of the retinal pigment epithelium–photoreceptor complex
Milićević, N. (2020) · theses.fr (ABES) · doi:10.70675/2a3b679cz473bz4c14zb33az700581cd794a
Biological rhythms in retinal development
Bagchi, U. (2022) · theses.fr (ABES) · doi:10.70675/f3adc3caz635bz4f0ezbd7az684aff912e21
Chronotherapy for retinopathy: Unraveling the mystery of Rev-erbα in the circadian rhythm
Qu, C.-K., Wu, H., Huang, Z.-X., Wang, Y., Wang, K.-X., Li, S., Pu, N., Zhang, J.-H., Ding, S.-A., Zhang, C.-X., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115676
Enhanced S-cone syndrome in a family: first long-term (12-year) follow-up and literature review
Pignatto, S., Martin, A. A., Gavrić, A. U., Meglič, A., Zan, E. R. D., & Lanzetta, P. (2026) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-026-07300-6
Metadata
- Authors
- Cruz, N. M., Yuan, Y., Leehy, B. D., Baid, R., Kompella, U., DeAngelis, M. M., Escher, P., & Haider, N. B.
- Affiliations
- Massachusetts Eye and Ear Infirmary (US)
- University of Nebraska Medical Center (US)
- University of Colorado Anschutz (US)
- University of Utah (US)
- Institut de Recherche en Opthalmologie (CH)
- Corresponding author
- Haider, Neena B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-31
- Volume
- 9
- Issue
- 1
- Pages
- e87942
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3909326
- OpenAlex
- W2031568258
- Cited by
- 47
- References
- 56
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Access CRIS of the University of Bern
- Funders
- Massachusetts Lions Eye Research Fund
- Edward N. and Della L. Thome Memorial Foundation
- Hope For Vision
- National Institutes of Health
- U.S. Public Health Service (P20-RRO18788-03)
- National Eye Institute (RO1EY017653-01A2S1, RO1EY017653, R01EY017653, T32EY007145)
- National Center for Research Resources
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- NR1D1, NR2E3, retinal degeneration, nuclear receptors, retinitis pigmentosa, enhanced S-cone syndrome, genetic modifiers, gene therapy, transcriptional regulation, retinal disease therapy
- MeSH terms
- Animals, Humans, Mice, Transgenic, Retinal Degeneration, Retinitis Pigmentosa, Vision Disorders, Genetic Therapy, Eye Diseases, Hereditary, Mice, Nuclear Receptor Subfamily 1, Group D, Member 1, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.